Scarica l'app Stockscreener
21.46
5.40%
1.10
Dopo l'orario di chiusura:
21.04
-0.42
-1.96%
Precedente Chiudi:
$20.36
Aprire:
$20.12
Volume 24 ore:
1.72M
Relative Volume:
1.75
Capitalizzazione di mercato:
$1.34B
Reddito:
$10.00M
Utile/perdita netta:
$-377.74M
Rapporto P/E:
-2.5416
EPS:
-8.4436
Flusso di cassa netto:
$-172.35M
1 W Prestazione:
-3.16%
1M Prestazione:
-16.04%
6M Prestazione:
+2.43%
1 anno Prestazione:
+154.57%
Intervallo 1D:
$19.81
$22.15
Intervallo di 1 settimana:
$17.20
$22.15
Portata 52W:
$6.11
$44.60
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Nome
Zenas Biopharma Inc
Settore
Industria
Telefono
857-271-2954
Indirizzo
852 WINTER STREET, SUITE 250, WALTHAM
Compare ZBIO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
21.46 | 1.34B | 10.00M | -377.74M | -172.35M | -8.4436 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-20 | Iniziato | Wedbush | Outperform |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Citigroup | Buy |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Zenas Biopharma Inc Borsa (ZBIO) Ultime notizie
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Zenas BioPharma's Key Milestones and Market Context: Holding Through the BLA (NASDAQ:ZBIO) - seekingalpha.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect - accessnewswire.com
Zenas BioPharma Director Makes Bold New Move With Fresh Stock Purchase - TipRanks
Zenas BioPharma Director Increases Stake with $70K Stock Purchase - National Today
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 By Investing.com - Investing.com Canada
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 - Investing.com
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock - MarketBeat
Leon Moulder boosts Zenas BioPharma (ZBIO) stake to 4.794% ownership - Stock Titan
Zenas BioPharma (ZBIO) director-affiliated funds purchase 3,768 shares - Stock Titan
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% Following Insider Buying Activity - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect | NDAQ:ZBIO | Press Release - Stockhouse
Zenas BioPharma (NASDAQ:ZBIO) Director Purchases $3,000,000.00 in Stock - MarketBeat
Akin, an Elite Global Law Firm - akingump.com
Zenas BioPharma (ZBIO): Does This $300 Million Raise Clarify or Complicate Its Funding Strategy? - Sahm
Major Insider Move Signals Growing Confidence in Zenas BioPharma’s Future - TipRanks
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Fairmount fund adds 150,000 Zenas BioPharma (ZBIO) shares - Stock Titan
ZBIO6353884 Bond Price and Chart — FINRA:ZBIO6353884 - TradingView
Zenas BioPharma, Inc. Bonds — Corporate Bond Rates - TradingView
Insider Makes Bold Million-Dollar Bet on Zenas BioPharma - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ZBIO Stock Price and Chart — NASDAQ:ZBIO - TradingView
54K-share open-market buy by CEO-linked entities at Zenas BioPharma (ZBIO) - Stock Titan
Zenas BioPharma Raises Capital via Notes and Equity Offering - TipRanks
Zenas BioPharma (ZBIO) CEO Moulder buys shares worth $1.02 million By Investing.com - Investing.com Australia
Zenas BioPharma (ZBIO) CEO Moulder buys shares worth $1.02 million - Investing.com
Lu Hongbo buys $1.5 million in Zenas Biopharma (ZBIO) stock - Investing.com
Lu Hongbo buys $1.5 million in Zenas Biopharma (ZBIO) stock By Investing.com - Investing.com Canada
Director-linked funds add 75K Zenas BioPharma (ZBIO) shares at $20 in offering - Stock Titan
Zenas BioPharma (ZBIO) raises capital via $200M converts and equity sale - Stock Titan
Form 424B5 Zenas BioPharma, Inc. - StreetInsider
Zenas BioPharma (NASDAQ: ZBIO) prices $200M convertible notes due 2032 - Stock Titan
[424B5] Zenas BioPharma, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
InnoCare Hits Profit Milestone, Relative Undervaluation Points To Stock Upside - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock - MSN
Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk - Yahoo Finance
ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Zenas BioPharma prices $300M capital raise in dual offering - MSN
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap DownShould You Sell? - MarketBeat
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Zenas BioPharma prices $200M convertible notes, $100M stock sale By Investing.com - Investing.com Canada
Zenas BioPharma Stock Pre-Market (-9.5%): Announces Concurrent Stock and Debt Offerings - Trefis
Zenas BioPharma Prices $287.5 Million Convertible Notes, Equity Offerings - MarketScreener
Zenas BioPharma prices $200M convertible notes, $100M stock sale - Investing.com
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million - The Manila Times
Zenas BioPharma launches convertible notes, stock offerings By Investing.com - ca.investing.com
Zenas BioPharma Announces Pricing of Concurrent Public - GlobeNewswire
Zenas BioPharma launches convertible notes, stock offerings - Investing.com
Zenas Biopharma Announces Proposed Concurrent Public Offerings Of Convertible Senior Notes Due 2032 And Common Stock - TradingView
Zenas Biopharma Inc Azioni (ZBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):